Icon

SEYSARA (nda209521)- (EQ 60MG BASE,EQ 100MG BASE,EQ 150MG BASE)

SARECYCLINE HYDROCHLORIDE ALMIRALL
EQ 60MG BASE,EQ 100MG BASE,EQ 150MG BASE
No No
2033-Feb-09 2023-Oct-01
None None
None No
SEYSARA® is a tetracycline-class drug indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 9 years of age and older.
0 0 0
Total Other Developers 2
Drugs with Suitability No
EQ 60MG BASE ** ** - - -
EQ 100MG BASE ** ** - - -
EQ 150MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.